Media Summary: In this video, Ellen Leinfuss, Senior Vice President, Certara, talks Certara accelerates medicines to patients Topics Covered: - Overview of the Advanced Deposition, Dissolution and Absorption

Simcyp Population Pbpk Modelling Using - Detailed Analysis & Overview

In this video, Ellen Leinfuss, Senior Vice President, Certara, talks Certara accelerates medicines to patients Topics Covered: - Overview of the Advanced Deposition, Dissolution and Absorption Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a cytotoxic anti-cancer drug ... Over the past two decades, there have been transformative changes in our approach to A presentation on the paper 'Application of

Watch this webinar to learn how physiologically based pharmacokinetic (

Photo Gallery

Simcyp Population PBPK modelling using parametric and nonparametric methods and Bayesian samplers
Developing Compound Files for PBPK Modeling in the Simcyp Simulator
An Introduction to PBPK, Simcyp Discovery, and the Simcyp Product Suite
Introduction to Inhalation PBPK Modelling in Simcyp
Common Myths about PBPK Modeling and Simulation- Busted!
Introduction to Ocular PBPK Modelling in Simcyp
Simcyp Workflow
PBPK Modeling of Antibody-Drug Conjugates – Concept and Application
Applications of PBPK modelling for regulatory submissions: case studies
PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information
PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches
QSP &  Simcyp Designer: Seamless & User-Friendly Integration of QSP and PBPK Models
View Detailed Profile
Simcyp Population PBPK modelling using parametric and nonparametric methods and Bayesian samplers

Simcyp Population PBPK modelling using parametric and nonparametric methods and Bayesian samplers

Comparison of results obtained

Developing Compound Files for PBPK Modeling in the Simcyp Simulator

Developing Compound Files for PBPK Modeling in the Simcyp Simulator

In this video, Ellen Leinfuss, Senior Vice President, Certara, talks

An Introduction to PBPK, Simcyp Discovery, and the Simcyp Product Suite

An Introduction to PBPK, Simcyp Discovery, and the Simcyp Product Suite

Certara accelerates medicines to patients

Introduction to Inhalation PBPK Modelling in Simcyp

Introduction to Inhalation PBPK Modelling in Simcyp

Topics Covered: - Overview of the Advanced Deposition, Dissolution and Absorption

Common Myths about PBPK Modeling and Simulation- Busted!

Common Myths about PBPK Modeling and Simulation- Busted!

Physiologically-based pharmacokinetic

Introduction to Ocular PBPK Modelling in Simcyp

Introduction to Ocular PBPK Modelling in Simcyp

Topics Covered: • Overview of the ocular

Simcyp Workflow

Simcyp Workflow

This e-learning video takes you

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a cytotoxic anti-cancer drug ...

Applications of PBPK modelling for regulatory submissions: case studies

Applications of PBPK modelling for regulatory submissions: case studies

Over the past two decades, there have been transformative changes in our approach to

PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information

PBPK Modeling and Simulation for Regulatory Decision Making: Impact on US Prescribing Information

A presentation on the paper 'Application of

PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches

PBPK modeling and simulation: Bridging the “Bottom Up” and “Top-Down” Approaches

Watch this webinar to learn how physiologically based pharmacokinetic (

QSP &  Simcyp Designer: Seamless & User-Friendly Integration of QSP and PBPK Models

QSP & Simcyp Designer: Seamless & User-Friendly Integration of QSP and PBPK Models

Certara accelerates medicines to patients

What's New in PBPK & the Simcyp Simulator

What's New in PBPK & the Simcyp Simulator

Certara accelerates medicines to patients